Solstice Advanced Materials Inc. SOLS Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $642M-3.9% | $534M-19.2% | $417M-35.3% | —— | $668M— | ||
| $632M+15,700% | $645M+13.4% | $635M— | —— | $4M— | ||
| $704M+1,753% | $715M+28.1% | $732M— | —— | $38M— | ||
| $2.44B— | $2.39B+28.3% | $1.88B— | —— | —— | ||
| $2.08B— | $2.06B+17.7% | $1.95B— | —— | —— | ||
| $819M— | $820M+1.7% | $820M— | —— | —— | ||
| $20M— | $21M-40.0% | $11M— | —— | —— | ||
| $5.75B— | $5.67B+13.4% | $5.25B— | —— | —— | ||
| $910M+4,889% | $909M+16.8% | $872M— | —— | -$19M— | ||
| $2.9B— | —— | $2.87B— | —— | —— | ||
| $6M— | $4M— | $13M— | —— | —— | ||
| $1.71B— | $1.71B+58.2% | $1.23B— | —— | —— | ||
| $2.11B— | $2.12B— | —— | —— | —— | ||
| $311M— | $300M+13.6% | $281M— | —— | —— | ||
| 500M— | 500M— | —— | —— | —— | ||
| $113M— | $41M— | —— | —— | —— | ||
| $1.49B-54.0% | $1.41B-56.7% | $3.23B+0.3% | $3.47B+10.8% | $3.23B— | ||
| $5.75B— | $5.67B+13.4% | $5.25B— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Solstice Advanced Materials Inc. 's total assets?
- Solstice Advanced Materials Inc. (SOLS) holds $5.7B in total assets.
- How much debt does Solstice Advanced Materials Inc. have?
- Solstice Advanced Materials Inc. carries $2.2B in total debt against $1.5B of shareholders' equity, a debt-to-equity ratio of 1.50.
- How much cash does Solstice Advanced Materials Inc. have?
- Solstice Advanced Materials Inc. holds $642.0M in cash and equivalents.
- Can Solstice Advanced Materials Inc. cover its short-term obligations?
- Its current ratio is 1.43 — current assets exceed current liabilities.
- Where does Solstice Advanced Materials Inc. 's balance sheet data come from?
- Every line is extracted from Solstice Advanced Materials Inc. 's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
